Safety and Efficacy of Directly Acting Antivirals in 2432 HCV Patients with Advanced Fibrosis: An Interim Analysis of the Lombardia Regional Network for Viral Hepatitis
Alessio Aghemo, M. Colombo(Ospedale Maggiore), Giuliana Cologni(University of Bergamo), L. Pasulo(Ospedale Papa Giovanni XXIII), Massimo Zuin(AOL (United States)), Agostino Colli(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Massimo Puoti(Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda), S. Fagiuoli(Ospedale Papa Giovanni XXIII), Maria Grazia Rumi(University of Milan), Giuliano Rizzardini, C. Magni(ASST Fatebenefratelli Sacco), G. Filice, L. Minoli(Policlinico San Matteo Fondazione), Franco Maggiolo(Ospedale Papa Giovanni XXIII), Tiziana Quirino(Ospedale di Circolo di Busto Arsizio)
Cited by 8
Related Papers
Antiretroviral Treatment of Adult HIV Infection
|JAMA|2010|725
Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study
|The Lancet. Gastroenterology & hepatology|2022|664
Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response.
|Journal of Clinical Investigation|1996|661
Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission
|The Lancet. Gastroenterology & hepatology|2019|539